{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:43:13Z","timestamp":1790095393185,"version":"4.0.1"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,12,15]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.271074","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:45:14Z","timestamp":1768578314000},"page":"584-589","source":"Crossref","is-referenced-by-count":2,"title":["Head-to-Head Comparison of [\n                    <sup>68<\/sup>\n                    Ga]Ga-DOTATATE PET\/CT and [\n                    <sup>68<\/sup>\n                    Ga]Ga-NODAGA-LM3 PET\/CT"],"prefix":"10.2967","volume":"67","author":[{"given":"Canan","family":"Can","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Kmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"Gzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiye","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hseyin","family":"Karaoglan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Gzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"mer","family":"Yeprem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Akyildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferat","family":"Kepenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026040105551068000_67.4.584.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70410-2"},{"key":"2026040105551068000_67.4.584.2","first-page":"582","article-title":"Management of well-differentiated neuroendocrine tumors","volume":"19","author":"Tella","year":"2021","journal-title":"Clin Adv Hematol Oncol."},{"key":"2026040105551068000_67.4.584.3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000441897","article-title":"Changes in the epidemiology of neuroendocrine tumours","volume":"104","author":"Huguet","year":"2017","journal-title":"Neuroendocrinology."},{"key":"2026040105551068000_67.4.584.4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.arcmed.2020.06.018","article-title":"An update on gastroenteropancreatic neuroendocrine neoplasms: from mysteries to paradigm shifts","volume":"51","author":"Ramrez-Rentera","year":"2020","journal-title":"Arch Med Res."},{"key":"2026040105551068000_67.4.584.5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000475526","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues","volume":"105","author":"Hicks","year":"2017","journal-title":"Neuroendocrinology."},{"key":"2026040105551068000_67.4.584.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026040105551068000_67.4.584.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202275"},{"key":"2026040105551068000_67.4.584.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264183"},{"key":"2026040105551068000_67.4.584.9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0026-895X(25)09370-8","article-title":"Identification and characterization of novel somatostatin antagonists","volume":"50","author":"Bass","year":"1996","journal-title":"Mol Pharmacol."},{"key":"2026040105551068000_67.4.584.10","first-page":"502","article-title":"Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists","volume":"47","author":"Cescato","year":"2006","journal-title":"J Nucl Med."},{"key":"2026040105551068000_67.4.584.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607761103"},{"key":"2026040105551068000_67.4.584.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199760"},{"key":"2026040105551068000_67.4.584.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.087999"},{"key":"2026040105551068000_67.4.584.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"2026040105551068000_67.4.584.15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/RLU.0000000000002276","article-title":"[68Ga]Ga PET imaging in patients with neuroendocrine tumors: a systematic review and meta-analysis","volume":"43","author":"Singh","year":"2018","journal-title":"Clin Nucl Med."},{"key":"2026040105551068000_67.4.584.16","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113496679"},{"key":"2026040105551068000_67.4.584.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.253096"},{"key":"2026040105551068000_67.4.584.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235093"},{"key":"2026040105551068000_67.4.584.19","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00259-021-05512-y","article-title":"A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE","volume":"49","author":"Zhu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551068000_67.4.584.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.061457"},{"key":"2026040105551068000_67.4.584.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.102764"},{"key":"2026040105551068000_67.4.584.22","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.2967\/jnumed.116.186783","article-title":"Somatostatin receptor antagonists for imaging and therapy","volume":"58(suppl 2)","author":"Fani","year":"2017","journal-title":"J Nucl Med."},{"key":"2026040105551068000_67.4.584.23","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.7150\/thno.94521","article-title":"First-in-human study of an optimized, potential kit-type, SSTR antagonist 68Ga-DATA5m-LM4 in patients with metastatic neuroendocrine tumors","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics."},{"key":"2026040105551068000_67.4.584.24","doi-asserted-by":"crossref","unstructured":"Liu M Zhang Y Yan X . Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET\/CT in patients with well-differentiated neuroendocrine tumors. Eur J Nucl Med Mol Imaging. August 5, 2025 [Epub ahead of print].","DOI":"10.1007\/s00259-025-07484-9"},{"key":"2026040105551068000_67.4.584.25","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1007\/s00259-024-06639-4","article-title":"Gallium-68 labeled somatostatin receptor antagonist PET\/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China","volume":"51","author":"Liu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551068000_67.4.584.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.180430"},{"key":"2026040105551068000_67.4.584.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.236091"},{"key":"2026040105551068000_67.4.584.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156539"},{"key":"2026040105551068000_67.4.584.29","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00259-021-05249-8","article-title":"Synthesis, preclinical evaluation, and a pilot clinical imaging study of [18F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [68Ga]Ga-DOTA-TATE","volume":"48","author":"Xie","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551068000_67.4.584.30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000381061","article-title":"Expression of somatostatin receptors 15 and dopamine receptor 2 in lung carcinoids: implications for a therapeutic role","volume":"101","author":"Kanakis","year":"2015","journal-title":"Neuroendocrinology."},{"key":"2026040105551068000_67.4.584.31","doi-asserted-by":"crossref","unstructured":"Nicolas GP Lafont MA McDougall L . First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET\/CT as part of the phase I\/II COPPER PET in NET study. Eur J Nucl Med Mol Imaging. May 24, 2025 [Epub ahead of print].","DOI":"10.1007\/s00259-025-07301-3"},{"key":"2026040105551068000_67.4.584.32","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/RLU.0000000000002906","article-title":"Successful intraarterial peptide receptor radionuclide therapy of DOTATOC-negative high-grade liver metastases of a pancreatic neuroendocrine neoplasm using 177Lu-DOTA-LM3","volume":"45","author":"Zhang","year":"2020","journal-title":"Clin Nucl Med."},{"key":"2026040105551068000_67.4.584.33","first-page":"101","article-title":"First successful in-human application of 225Ac-DOTA-LM3 Mono-PRRT for the treatment of an otherwise therapy-resistant neuroendocrine tumor (NET G3)","volume":"50","author":"Speicher","year":"2025","journal-title":"Clin Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:31Z","timestamp":1785269911000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.271074"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271074","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}